Industry Leaders Join Forces to Streamline Compliance
Chemular and IGEN are teaming up to develop an innovative CaaS platform aimed at the success and growth of emerging businesses in tobacco and other highly regulated industries.
"The time and effort required to stay compliant with federal, state, and local laws is increasingly burdensome for small- to mid-sized companies in regulated categories," says
In addition to saving time, utilizing the new CaaS platform can provide regulated companies with many other benefits, including:
- Streamlined remittance and reporting for Excise Tax, PACT Act, state registrations, and license capture.
- Optimized growth opportunities by allowing employees and leadership to focus on what they do best: developing products and services.
- Avoiding penalties with scaled compliance efforts that easily adapt to new markets with potentially different laws and regulations as the company grows.
- Reducing risk by monitoring real-time data and evolving regulations, while establishing automated procedures that can minimize errors and detect fraud.
Failure to adhere to compliance guidelines can be costly for companies, leading to large fines and expensive sanctions, regulatory scrutiny, and loss of trust in the marketplace. In some cases, non-compliant companies can have their products removed from store shelves, giving space to competitors who were able to better adjust to changing regulations.
"Compliance can be a long-term strategic advantage yet most emerging businesses don't have the resources and expertise to keep up with the growing complexity in regulatory requirements," says
Along with this announcement, the Chemular and IGEN teams will be appearing at the tobacco industry's largest tradeshow, TPE24, providing resources and education to the show's retail attendees. Chemular will be hosting the "Fortify Your Future" educational sessions of the show from
Companies interested in becoming compliant or streamlining their current processes can visit www.chemular.com for more information.
About Chemular
Founded in 2015 by a group of industry and FDA experts in tobacco, nicotine, medical devices, and compliance, Chemular is a highly focused regulatory consulting group dedicated to the tobacco space. Their team of tobacco-specific toxicologists, chemists, clinical trial experts, project managers and affiliated companies are leading and shaping the market with a full range of regulatory and manufacturing solutions, specializing in areas like raw material distribution, regulatory consulting, product development, and complete or partial assistance with PMTA submissions, EU TPD filings, PACT act compliance, and SDS sheet creations. Chemular has an established global reach that includes
About IGEN
As a top compliance software company, IGEN empowers businesses in heavily regulated industries to gain visibility into compliance activities and navigate the regulatory landscape seamlessly. IGEN's comprehensive compliance platform, ComplyIQ, is the complete toolkit for reducing redundancy and risk, while managing compliance implications across the organization. ComplyIQ offers tools for preparing and reconciling compliance data, managing licenses, calculating taxes, reporting PACT & excise, and more. Explore more at www.complyiq.io.
View original content to download multimedia:https://www.prnewswire.com/news-releases/industry-leaders-join-forces-to-streamline-compliance-302045865.html
SOURCE IGEN
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VEVOR Monthly Power 15 Returns August 15-18, Powering the Back-to-Project Season
- Knott's Berry Farm Relaunches Historic Montezooma's Revenge as MonteZOOMa: The Forbidden Fortress
- Nocpix Nature Launches Rovex, a Large-Screen Thermal Solution for Faster Bird Discovery
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share